KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,674,590 | -37.1% | 3,357,884 | +4.1% | 0.00% | -50.0% |
| Q2 2023 | $74,162,199 | -24.8% | 3,225,846 | -3.1% | 0.00% | -33.3% |
| Q1 2023 | $98,673,530 | +18.5% | 3,330,190 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $83,239,129 | +19.3% | 3,334,901 | +4.1% | 0.00% | +50.0% |
| Q3 2022 | $69,767,000 | +25.3% | 3,204,682 | +13.3% | 0.00% | 0.0% |
| Q2 2022 | $55,691,000 | -61.5% | 2,828,434 | -17.3% | 0.00% | -50.0% |
| Q1 2022 | $144,698,000 | -32.9% | 3,419,084 | +0.6% | 0.00% | -20.0% |
| Q4 2021 | $215,709,000 | +20.8% | 3,397,540 | +11.7% | 0.01% | 0.0% |
| Q3 2021 | $178,595,000 | +50.4% | 3,040,431 | +24.2% | 0.01% | +66.7% |
| Q2 2021 | $118,754,000 | +101.9% | 2,448,517 | +61.7% | 0.00% | +50.0% |
| Q1 2021 | $58,831,000 | -33.0% | 1,513,923 | +6.9% | 0.00% | -33.3% |
| Q4 2020 | $87,832,000 | +254.6% | 1,416,631 | +84.8% | 0.00% | +200.0% |
| Q3 2020 | $24,769,000 | – | 766,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |